Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Mark A. Fisher"'
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bloodstream infections (BSI) are associated with increased cost, morbidity, and mortality compared with BSI by non-ESBL-producing bacteria. Phenotypic susceptibility data fro
Externí odkaz:
https://doaj.org/article/4cb438948ce148118ee9518f29218626
Autor:
Albebson L. Lim, Bailey W. Miller, Zhenjian Lin, Mark A. Fisher, Louis R. Barrows, Margo G. Haygood, Eric W. Schmidt
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT Turnercyclamycin A and B lipopeptides exhibit Gram-negative bacteria-specific toxicity. This includes CDC urgent threat organisms such as multidrug-resistant Acinetobacter baumannii. Like the last-line agent colistin, turnercyclamycins inter
Externí odkaz:
https://doaj.org/article/54c4046ef672420ebbd5753d2a69f3bd
Autor:
D. Garrett Brown, Taylor A. Wahlig, Angela Ma, Laura K. Certain, Peter N. Chalmers, Mark A. Fisher, Daniel T Leung
Publikováno v:
Pathogens and Immunity, Vol 8, Iss 1 (2023)
Background: Cutibacterium acnes is a common commensal of human skin but may also present as an opportunistic pathogen in prosthetic joint and wound infections. Unfortunately, few complete genomes of C. acnes are publicly available, and even fewer are
Externí odkaz:
https://doaj.org/article/31f6c99fe3ea495b8ef3ddb653f06517
Autor:
Salika M. Shakir, Rahul Gill, Jonathan Salberg, E. Susan Slechta, Mark Feldman, Thomas Fritsche, Jill Clarridge, Susan E. Sharp, Mark A. Fisher
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 5, Pp 1309-1316 (2021)
Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection
Externí odkaz:
https://doaj.org/article/39d669967f244af2b2afc7f6700a26dd
Autor:
Brian M. Forde, Leah W. Roberts, Minh-Duy Phan, Kate M. Peters, Brittany A. Fleming, Colin W. Russell, Sara M. Lenherr, Jeremy B. Myers, Adam P. Barker, Mark A. Fisher, Teik-Min Chong, Wai-Fong Yin, Kok-Gan Chan, Mark A. Schembri, Matthew A. Mulvey, Scott A. Beatson
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
Recurrent urinary tract infections occur in ~ 25% of women. Here, Beatson and colleagues use whole genome sequencing to track the dynamics of an E. coli ST131 clone in a single patient over a 5-year period. This study provides unique insights into pa
Externí odkaz:
https://doaj.org/article/11f7fed19dfc4a08914112598df22ee1
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 3, Pp 422-430 (2012)
Sequencing of the 16S rRNA gene (16S) is a reference method for bacterial identification. Its expanded use has led to increased recognition of novel bacterial species. In most clinical laboratories, novel species are infrequently encountered, and the
Externí odkaz:
https://doaj.org/article/601085ba210040d6ba44232ed89447a9
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 8, Pp 1378-1379 (2012)
Externí odkaz:
https://doaj.org/article/e25abf88c7ff4f1ca774f785f359f157
Autor:
Matthew J. McLaughlin, Mark T. Fisher
Publikováno v:
Journal of Pediatric Rehabilitation Medicine. 16:3-9
Autor:
Brandon S. Walker, Robert L. Schmidt, Ryleigh A. Moore, Sandra K. White, Mark A. Fisher, Ryan A. Metcalf
Publikováno v:
Transfusion. 63:182-192
Non-pathogen reduction platelet bacterial risk control strategies in the US FDA guidance include at least one culture. Almost all of these strategies have a culture hold time of ≥12 h. Studies have reported time to detection (TTD) of bacterial cult
Publikováno v:
Ophthalmic Plastic & Reconstructive Surgery.